About us
Pioneering Biosynthetic Cellulose with epicite®
The story of JeNaCell began in the university city of Jena, Germany and centers on the inspiring journey of Dr. Dana Kralisch, whose determination led to the development of an innovative new technology. A passionate pharmaceutical scientist and professor at the Friedrich Schiller University, Dana had a particular fascination with the natural sciences.
It was during her research that she made a groundbreaking discovery: biosynthetic cellulose, a nature-inspired material produced by bacteria through a sophisticated fermentation process. Recognizing the immense potential of this versatile material, Dana strove to translate her scientific findings into real-world applications. In 2012, she took a bold step, founding JeNaCell as a spin-off from the university.
Her vision was clear: to upscale and market biosynthetic cellulose for clinical applications, transforming the landscape of wound care.
After years of dedicated research and development, JeNaCell proudly launched its first product, epicite®—a hydro-active dressing designed for advanced wound care. The initial application of epicite® was in the treatment of burns, specifically second degree burns, where it has been utilized in clinical settings for years. This product not only demonstrates the effectiveness of biosynthetic cellulose but also highlights JeNaCell's commitment to enhancing patient outcomes through innovative solutions.
„With epicite®, we harness the power of biosynthetic cellulose to promote faster recovery and enhance the quality of life for millions of patients worldwide. This nature-inspired solution is designed to make a meaningful difference in wound care.“
Dr. Dana Kralisch,
General Manager & Founder of JeNaCell
Dana's energetic leadership and unwavering focus on new goals have propelled JeNaCell forward. Together with her interdisciplinary team of specialists in biochemistry, pharmacy, and biotechnology, JeNaCell successfully introduced the second product in the epicite® family in 2023: epicite® balance. This new offering is specifically designed for the treatment of chronic wounds, particularly in outpatient settings, showcasing JeNaCell's dedication to addressing diverse medical needs.
Continuing this trajectory of growth and innovation, JeNaCell recently launched epicite® calm, targeting the medical aesthetics market. This product further complements the epicite® portfolio, reinforcing Dana’s vision of expanding the company’s reach and impact in the healthcare sector.
Highest safety and quality standards for medical-grade portfolio
All products in the epicite® family are medical-grade and manufactured under stringent cleanroom conditions at JeNaCell’s state-of-the-art facility in Jena. The production site is certified according to ISO 13485:2016, the leading quality system for medical devices, ensuring that every epicite® product meets the highest safety and quality standards. These products are sterilized through irradiation, making them safe for use on irritated and treatment-prone skin and wounds.
The story of JeNaCell is a testament to the power of innovation, collaboration, and perseverance. From a scientific discovery in a university lab to a thriving company making significant contributions to wound care, Dana Kralisch’s vision continues to inspire. As JeNaCell moves forward, the company remains committed to harnessing the potential of biosynthetic cellulose to improve lives and set new standards in medical care.